Alkem Laboratories gets eight observations from UK health regulator for Taloja plant

01 Apr 2016 Evaluate

UK health regulator has made eight observations at Alkem Laboratories’ manufacturing plant at Taloja, Maharashtra. The Medicines and Healthcare Products Regulator Agency (UKMHRA) had conducted an inspection at the company's facility at Taloja earlier this month with respect to marketing authorisation applications made by the company to the EU countries. The company has received inspection report from the UKMHRA on March 30 where 8 observations have been made by the regulator.

Alkem Laboratories is engaged in manufacturing and distributing pharmaceuticals products. It offers active pharmaceutical ingredient (API), generic, branded and nutraceuticals products under the brand name Clavm, Pan20, Pan40, Sumo. The firm also provides formulations for acute and chronic therapeutic focusing on anti-infective, gastrointestinal, cardiovascular, anti-diabetic, and pain management segments.

Alkem Laboratories Share Price

5727.30 -14.55 (-0.25%)
20-Jan-2026 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.15
Dr. Reddys Lab 1175.25
Cipla 1380.40
Zydus Lifesciences 876.45
Lupin 2170.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×